ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2023. The put-call ratio across all filers is 16.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,916,820 | – | 1,495,805 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,680,149 | $45,633,000 | 9.77% |
Grosvenor Holdings, L.L.C. | 1,517,212 | $41,207,000 | 5.05% |
Redmile Group, LLC | 7,529,329 | $204,497,000 | 3.57% |
Indie Asset Partners, LLC | 97,411 | $2,646,000 | 2.14% |
MPM BioImpact LLC | 344,519 | $9,357,000 | 1.45% |
Eventide Asset Management | 1,311,990 | $35,634,000 | 0.47% |
Virtus ETF Advisers LLC | 19,728 | $536,000 | 0.24% |
HHLR ADVISORS, LTD. | 500,000 | $13,580,000 | 0.18% |
CNA FINANCIAL CORP | 14,805 | $402,000 | 0.11% |
Employees Retirement System of Texas | 230,000 | $6,247,000 | 0.07% |